Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients
Published in Clinical Pharmacology & Therapeutics (CPT), 2020
Recommended citation: Yang, C.Y., Lin, W.A., Su, P.F., Li, L.J., Yang, C.T., Ou, H.T. and Kuo, S. (2021). "Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients" Clinical Pharmacology & Therapeutics (CPT). 109(3):772-781.
Download Paper